Plutux
$1.11
-2.63%
2026-09-03 13:45:00 EDT-$0.03
Basic Materials
Chemicals - Specialty
NASDAQ
Active Trading

Bon Natural Life Limited, accompanied by its various subsidiaries, focuses on the innovation, production, and worldwide distribution of active functional compounds sourced ...

Price Action

$1.11
-2.63%-$0.03
High
Low
52W High-52.6%
Rel. vol
Interval
Range5.1h
VolumeSMA5SMA10
Bon Natural Life Limited (NASDAQ: BON) is a Cayman Islands–incorporated company with operating presence associated with Xi’an, China, focused on the research, development, manufacture, and worldwide distribution of functional active ingredients sourced from natural plant extracts. Founded in 2006 and led by CEO Yongwei Hu, the company positions itself as ...Bon Natural Life Limited (NASDAQ: BON) is a Cayman Islands–incorporated company with operating presence associated with Xi’an, China, focused on the research, development, manufacture, and worldwide distribution of functional active ingredients sourced from natural plant extracts. Founded in 2006 and led by CEO Yongwei Hu, the company positions itself as a modern biotechnology/ingredient provider for industries that rely on bio-derived inputs—particularly personal care, functional foods, cosmetics, and related sectors such as pharmaceutical-adjacent applications. From a business perspective, BON’s core model centers on turning natural plant materials into standardized and usable functional compounds. The company’s product mix is oriented around (1) personal care ingredients, such as plant-derived aromatic compounds supplied to manufacturers of perfumes and fragrances; and (2) natural health/functional nutrition offerings, including powdered beverages and biologically active food ingredients intended for use as food additives. In addition, BON offers nutritional supplements, generally serving industrial customers and downstream manufacturers who use these inputs in consumer-facing end products. Product and service activities described for the company emphasize innovation and production of “active functional compounds,” suggesting a workflow that typically includes R&D, extraction/processing, formulation/standardization, and commercial distribution. The company’s customers are primarily industrial clients in functional food, personal care/cosmetics, and healthcare-adjacent categories, meaning BON’s value proposition is closely tied to consistent ingredient performance, sourcing and extraction capabilities, and the ability to scale supply for buyer product development. In cost and operating terms, the provided dataset indicates profitability pressure in recent TTM metrics (e.g., negative margins such as net profit margin and operating profit margin). While the dataset also reports liquidity and working capital measures, specific operational drivers (gross vs. operating cost structure, capacity utilization, and inventory policy details) are not fully disclosed in the provided text. Nonetheless, the business profile implies that the company’s cost structure is influenced by R&D intensity (noted in the dataset as a portion of revenue), manufacturing/extraction costs, and working-capital dynamics typical of ingredient businesses with inventory and receivables requirements. Financially, the enterprise value and valuation ratios provided suggest the market is pricing the company with caution relative to sales/earnings power. For example, price-to-sales is reported as relatively low, while free cash flow-related metrics are negative in the dataset snapshot, consistent with an investment and development phase or challenging profitability. Key people highlighted include Yongwei Hu as founder/CEO and other senior leadership such as Wallace Lee (CFO), Yingchun Xue (COO), and Wenjuan Chen (senior leadership roles). The company’s “wishes” or strategic direction, based on the stated mission language, appears focused on innovation and expanding global distribution of plant-extract functional ingredients, supporting customer product pipelines in personal care and functional nutrition. Overall, BON’s profile is that of a niche functional-ingredient manufacturer leveraging plant-extraction and biotechnology-oriented processes to supply downstream manufacturers with bioactive components, balancing R&D development needs with the realities of scaling production and achieving sustained profitability.
Founded
2006
Employees
96
CEO
Yongwei Hu
Full Name
Bon Natural Life Limited
Sector
Basic Materials
Industry
Chemicals - Specialty
ROE
-3.59%
Market Cap
$0.01B
Current Ratio
1.74
WACC
4.03%
ROIC
-3.43%

Contact Information

+86 29 8831 4820
Block C, Gazelle Valley, Xi'an, SA 710060

Related stocksChemicals - Specialty

Browse all US stocks

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026